The global Human Biofluid Collection Services market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
Human biofluid collection services refer to the professional services that involve the collection, processing, and storage of various biofluid samples obtained from human donors. These biofluids may include blood, urine, saliva, cerebrospinal fluid, and others. The collection services are typically carried out by trained healthcare professionals or specialized organizations following strict ethical guidelines and standard operating procedures. The collected biofluid samples are then processed, analyzed, and stored for various research purposes, such as biomarker discovery, disease diagnosis, therapeutic development, and genetic studies. These services play a crucial role in advancing medical and scientific research by providing researchers with access to high-quality human biofluid samples for their studies.
United States market for Human Biofluid Collection Services is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Human Biofluid Collection Services is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Human Biofluid Collection Services is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Human Biofluid Collection Services players cover Fidelis, Labtoo, Infiuss Health, Creative Bioarray, Finddx, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
The 鈥淗uman Biofluid Collection Services Industry Forecast鈥 looks at past sales and reviews total world Human Biofluid Collection Services sales in 2024, providing a comprehensive analysis by region and market sector of projected Human Biofluid Collection Services sales for 2025 through 2031. With Human Biofluid Collection Services sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Human Biofluid Collection Services industry.
This Insight Report provides a comprehensive analysis of the global Human Biofluid Collection Services landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Human Biofluid Collection Services portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥 unique position in an accelerating global Human Biofluid Collection Services market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Human Biofluid Collection Services and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Human Biofluid Collection Services.
This report presents a comprehensive overview, market shares, and growth opportunities of Human Biofluid Collection Services market by product type, application, key players and key regions and countries.
Segmentation by Type:
Blood
Cerebrospinal Fluid
Saliva
Others
Segmentation by Application:
Biopharmaceutical
Clinical Trials
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Fidelis
Labtoo
Infiuss Health
Creative Bioarray
Finddx
US Biolab
BioIVT
Ispecimen
Proteogenex
Bay Biosciences
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Human Biofluid Collection Services 麻豆原创 Size (2020-2031)
2.1.2 Human Biofluid Collection Services 麻豆原创 Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Human Biofluid Collection Services by Country/Region (2020, 2024 & 2031)
2.2 Human Biofluid Collection Services Segment by Type
2.2.1 Blood
2.2.2 Cerebrospinal Fluid
2.2.3 Saliva
2.2.4 Others
2.3 Human Biofluid Collection Services 麻豆原创 Size by Type
2.3.1 Human Biofluid Collection Services 麻豆原创 Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Human Biofluid Collection Services 麻豆原创 Size 麻豆原创 Share by Type (2020-2025)
2.4 Human Biofluid Collection Services Segment by Application
2.4.1 Biopharmaceutical
2.4.2 Clinical Trials
2.5 Human Biofluid Collection Services 麻豆原创 Size by Application
2.5.1 Human Biofluid Collection Services 麻豆原创 Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Human Biofluid Collection Services 麻豆原创 Size 麻豆原创 Share by Application (2020-2025)
3 Human Biofluid Collection Services 麻豆原创 Size by Player
3.1 Human Biofluid Collection Services 麻豆原创 Size 麻豆原创 Share by Player
3.1.1 Global Human Biofluid Collection Services Revenue by Player (2020-2025)
3.1.2 Global Human Biofluid Collection Services Revenue 麻豆原创 Share by Player (2020-2025)
3.2 Global Human Biofluid Collection Services Key Players Head office and Products Offered
3.3 麻豆原创 Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Human Biofluid Collection Services by Region
4.1 Human Biofluid Collection Services 麻豆原创 Size by Region (2020-2025)
4.2 Global Human Biofluid Collection Services Annual Revenue by Country/Region (2020-2025)
4.3 Americas Human Biofluid Collection Services 麻豆原创 Size Growth (2020-2025)
4.4 APAC Human Biofluid Collection Services 麻豆原创 Size Growth (2020-2025)
4.5 Europe Human Biofluid Collection Services 麻豆原创 Size Growth (2020-2025)
4.6 Middle East & Africa Human Biofluid Collection Services 麻豆原创 Size Growth (2020-2025)
5 Americas
5.1 Americas Human Biofluid Collection Services 麻豆原创 Size by Country (2020-2025)
5.2 Americas Human Biofluid Collection Services 麻豆原创 Size by Type (2020-2025)
5.3 Americas Human Biofluid Collection Services 麻豆原创 Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Human Biofluid Collection Services 麻豆原创 Size by Region (2020-2025)
6.2 APAC Human Biofluid Collection Services 麻豆原创 Size by Type (2020-2025)
6.3 APAC Human Biofluid Collection Services 麻豆原创 Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Human Biofluid Collection Services 麻豆原创 Size by Country (2020-2025)
7.2 Europe Human Biofluid Collection Services 麻豆原创 Size by Type (2020-2025)
7.3 Europe Human Biofluid Collection Services 麻豆原创 Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Human Biofluid Collection Services by Region (2020-2025)
8.2 Middle East & Africa Human Biofluid Collection Services 麻豆原创 Size by Type (2020-2025)
8.3 Middle East & Africa Human Biofluid Collection Services 麻豆原创 Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Global Human Biofluid Collection Services 麻豆原创 Forecast
10.1 Global Human Biofluid Collection Services Forecast by Region (2026-2031)
10.1.1 Global Human Biofluid Collection Services Forecast by Region (2026-2031)
10.1.2 Americas Human Biofluid Collection Services Forecast
10.1.3 APAC Human Biofluid Collection Services Forecast
10.1.4 Europe Human Biofluid Collection Services Forecast
10.1.5 Middle East & Africa Human Biofluid Collection Services Forecast
10.2 Americas Human Biofluid Collection Services Forecast by Country (2026-2031)
10.2.1 United States 麻豆原创 Human Biofluid Collection Services Forecast
10.2.2 Canada 麻豆原创 Human Biofluid Collection Services Forecast
10.2.3 Mexico 麻豆原创 Human Biofluid Collection Services Forecast
10.2.4 Brazil 麻豆原创 Human Biofluid Collection Services Forecast
10.3 APAC Human Biofluid Collection Services Forecast by Region (2026-2031)
10.3.1 China Human Biofluid Collection Services 麻豆原创 Forecast
10.3.2 Japan 麻豆原创 Human Biofluid Collection Services Forecast
10.3.3 Korea 麻豆原创 Human Biofluid Collection Services Forecast
10.3.4 Southeast Asia 麻豆原创 Human Biofluid Collection Services Forecast
10.3.5 India 麻豆原创 Human Biofluid Collection Services Forecast
10.3.6 Australia 麻豆原创 Human Biofluid Collection Services Forecast
10.4 Europe Human Biofluid Collection Services Forecast by Country (2026-2031)
10.4.1 Germany 麻豆原创 Human Biofluid Collection Services Forecast
10.4.2 France 麻豆原创 Human Biofluid Collection Services Forecast
10.4.3 UK 麻豆原创 Human Biofluid Collection Services Forecast
10.4.4 Italy 麻豆原创 Human Biofluid Collection Services Forecast
10.4.5 Russia 麻豆原创 Human Biofluid Collection Services Forecast
10.5 Middle East & Africa Human Biofluid Collection Services Forecast by Region (2026-2031)
10.5.1 Egypt 麻豆原创 Human Biofluid Collection Services Forecast
10.5.2 South Africa 麻豆原创 Human Biofluid Collection Services Forecast
10.5.3 Israel 麻豆原创 Human Biofluid Collection Services Forecast
10.5.4 Turkey 麻豆原创 Human Biofluid Collection Services Forecast
10.6 Global Human Biofluid Collection Services Forecast by Type (2026-2031)
10.7 Global Human Biofluid Collection Services Forecast by Application (2026-2031)
10.7.1 GCC Countries 麻豆原创 Human Biofluid Collection Services Forecast
11 Key Players Analysis
11.1 Fidelis
11.1.1 Fidelis Company Information
11.1.2 Fidelis Human Biofluid Collection Services Product Offered
11.1.3 Fidelis Human Biofluid Collection Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.1.4 Fidelis Main Business Overview
11.1.5 Fidelis Latest Developments
11.2 Labtoo
11.2.1 Labtoo Company Information
11.2.2 Labtoo Human Biofluid Collection Services Product Offered
11.2.3 Labtoo Human Biofluid Collection Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.2.4 Labtoo Main Business Overview
11.2.5 Labtoo Latest Developments
11.3 Infiuss Health
11.3.1 Infiuss Health Company Information
11.3.2 Infiuss Health Human Biofluid Collection Services Product Offered
11.3.3 Infiuss Health Human Biofluid Collection Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.3.4 Infiuss Health Main Business Overview
11.3.5 Infiuss Health Latest Developments
11.4 Creative Bioarray
11.4.1 Creative Bioarray Company Information
11.4.2 Creative Bioarray Human Biofluid Collection Services Product Offered
11.4.3 Creative Bioarray Human Biofluid Collection Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.4.4 Creative Bioarray Main Business Overview
11.4.5 Creative Bioarray Latest Developments
11.5 Finddx
11.5.1 Finddx Company Information
11.5.2 Finddx Human Biofluid Collection Services Product Offered
11.5.3 Finddx Human Biofluid Collection Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.5.4 Finddx Main Business Overview
11.5.5 Finddx Latest Developments
11.6 US Biolab
11.6.1 US Biolab Company Information
11.6.2 US Biolab Human Biofluid Collection Services Product Offered
11.6.3 US Biolab Human Biofluid Collection Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.6.4 US Biolab Main Business Overview
11.6.5 US Biolab Latest Developments
11.7 BioIVT
11.7.1 BioIVT Company Information
11.7.2 BioIVT Human Biofluid Collection Services Product Offered
11.7.3 BioIVT Human Biofluid Collection Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.7.4 BioIVT Main Business Overview
11.7.5 BioIVT Latest Developments
11.8 Ispecimen
11.8.1 Ispecimen Company Information
11.8.2 Ispecimen Human Biofluid Collection Services Product Offered
11.8.3 Ispecimen Human Biofluid Collection Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.8.4 Ispecimen Main Business Overview
11.8.5 Ispecimen Latest Developments
11.9 Proteogenex
11.9.1 Proteogenex Company Information
11.9.2 Proteogenex Human Biofluid Collection Services Product Offered
11.9.3 Proteogenex Human Biofluid Collection Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.9.4 Proteogenex Main Business Overview
11.9.5 Proteogenex Latest Developments
11.10 Bay Biosciences
11.10.1 Bay Biosciences Company Information
11.10.2 Bay Biosciences Human Biofluid Collection Services Product Offered
11.10.3 Bay Biosciences Human Biofluid Collection Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.10.4 Bay Biosciences Main Business Overview
11.10.5 Bay Biosciences Latest Developments
12 Research Findings and Conclusion
听
听
*If Applicable.